ESR(01821.HK)完成收購亞騰資產管理
置富產業信託(00778.HK)及泓富產業信託(00808.HK)公佈,ESR(01821.HK)收購亞騰於昨日(20日)完成。置富資產管理有限公司(管理人)爲置富產業信託之管理人及亞騰之附屬公司。泓富產業信託之管理人泓富資產管理有限公司,爲亞騰之全資附屬公司。透過該收購,ESR將間接擁有置富資產管理及泓富資產管理100%的股份,併成爲兩者的關連人士。
儘管理人所知,目前無意就該收購對置富產業信託和泓富產業信託的業務作出任何重大變動,亦無意就該收購對兩者的董事及高級管理層作出任何變動,管理人因該收購而帶來的控制權變更,不會對兩者的營運或財務產生任何重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.